Net shares · 365d
-50.0K
0 buy · 50.0K sell
Net value · 365d
-$55.8K
$0 in · $55.8K out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
4
0 buy · 50.0K sell
Trading track record · all companies
Not enough open-market trades to chart a track record yet.
Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.
Transactions · 365d
-
GETY Sell·S
Chief Marketing Officer · 10b5-1
$24.6K
31.6K sh · $0.78
Own -6%
-
GETY Sell·S
Chief Marketing Officer
$7.5K
5.9K sh · $1.27
Own -1%
-
GETY Sell·S
Chief Marketing Officer
$12.6K
6.2K sh · $2.03
Own -1%
-
GETY Sell·S
Chief Marketing Officer
$11.1K
6.3K sh · $1.77
Own -1%
| Date▾ | Ticker | Type | Shares | Value |
|---|---|---|---|---|
| Mar 25, 2026 | GETY | Sell S | 31.6K | $24.6K |
| Dec 24, 2025 | GETY | Sell S | 5.9K | $7.5K |
| Sep 24, 2025 | GETY | Sell S | 6.2K | $12.6K |
| Jun 25, 2025 | GETY | Sell S | 6.3K | $11.1K |
Buy Sell Non-market (grant · exercise · gift)
About Foca Gene
This profile aggregates every SEC Form 4 insider transaction reported by Foca Gene across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.